Cellusion Inc.

Cellusion have developed three main technologies for solving global cornea shortage issue, which are novel cell transplantation method for Bullous Keratopathy treatment, mass production technology to produce corneal endothelial cell from iPS cells, spheroid transplantation method to enhance the treatment efficacy. With these cellular technology breakthroughs, we will contribute to provide the clear vision of the future for worldwide patients.

Cellusion

ビジネス情報

会社名

Cellusion Inc.

設立

2015

位置

Tokyo, JP

からのスピンアウト

その他の場所

テクノロジーの検証

TRL

5

特許の価値

ビジネスステージ

Series A stage
Series B stage

ターゲット出口

IPO in Japan
Trade sales

次の投資要件

$2m to $3m

ビジネスパートナーへのメッセージ

Cellusion always welcomes to join our team as whoever solving global blindness issue together. Regardless of collaboration or investment etc., please feel free to contact us. Why don’t we discuss what we can do together?

主要な文献

To be updated